Location and intensity of IL-8 and TGF-β2 mRNA production in the fimbrial compartment of fallopian tubes and IL-10 in the endometrium in patients with pyoinflammatory adnexal diseases

Bulletin of Experimental Biology and Medicine

Volumn 135, Issue 3, 2003, Pages 272-275

  Zhdanov, A V ^a   Kurbanova, D F ^b   Sosulina, L Yu ^c   Davydova, M P ^d   Ezhova, L S ^a   Sukhikh, G T ^a  

^a INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

^b I M SECHENOV FIRST MOSCOW STATE MEDICAL UNIVERSITY   (Russian Federation)

^c SHEMYAKIN OVCHINNIKOV INSTITUTE OF BIOORGANIC CHEMISTRY   (Russian Federation)

^d LOMONOSOV MOSCOW STATE UNIVERSITY   (Russian Federation)

Author keywords

Cytokines; Endometrium; Fimbrial compartment; In situ hybridization; Inflammation of fallopian tubes

Indexed keywords

CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 8; INTERLEUKIN 9; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA2;

ADNEXA DISEASE; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENDOMETRIUM; EPITHELIUM CELL; FEMALE; FEMALE GENITAL TRACT INFLAMMATION; FIMBRIA; GENE EXPRESSION; HUMAN; IMMUNE RESPONSE; IN SITU HYBRIDIZATION; INFLAMMATORY INFILTRATE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; UTERINE TUBE;

ADNEXAL DISEASES; ADULT; ENDOMETRIUM; FALLOPIAN TUBES; FEMALE; HUMANS; IN SITU HYBRIDIZATION; INFLAMMATION; INTERLEUKIN-10; INTERLEUKIN-8; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA2;

FALLOPIA;

EID: 0042196314     PISSN: 00074888     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1024193216377     Document Type: Article

References (15)

1. A. V. Zhdanov, M. P. Davydova, D. F. Kurbanova, et al., Byull. Eksp. Biol. Med., 135, No. 2, 201-204 (2003).
2. A. V. Zhdanov, L. Yu. Sosulina, D. F. Kurbanova, et al., Ibid., 134, No. 11, 555-559 (2002).
3. Z. P. Milovanova, Dehydration and Embedding of Material. Microscopic Technique, Eds. D. S. Sarkisov and Yu. L. Perov [in Russian], Moscow (1996), pp. 14-25.
4. E. Baumgard, A. Schad, M. Grabenbauer, Immunocytochemistry and In Situ Hybridization in the Biomedical Science, Ed. J. E. Beesley, Boston (2001), pp. 108-138.
5. F. M. Brennan and M. Femdman, The Cytokine Network, Ed. F. Balkwill, Oxford (2000), pp. 49-70.
6. A. Fontana, D. B. Constam, K. Frei, et al., Int. Arch. Allergy Immunol., 99, No. 1, 1-7 (1992).
7. C. M. Hogaboam, B. A. Vallance, A. Kumar, et al., J. Clin. Invest., 100, No. 11, 2766-2776 (1997).
8. F. K. Li, A. Davenport, R. L. Robson, et al., Kidney Int., 54, No. 6, 2170-2183 (1998).
9. P. Montravers, L. Maulin, J. Mohler, and C. Carbon, Infect. Immun., 67, No. 4, 1579-1584 (1999).
10. S. Ohkawara, K. Goto, S. Mori, et al., Dermatologica, 179, Suppl. 1, 84-90 (1989).
11. S. F. Palter, N. Mulayim, L. Senturk, and A. Arici, J. Clin. Endocrinol. Metab., 86, No. 6, 2660-2667 (2001).
12. Y. Sakashita, E. Hiyama, Y. Imamura, et al., Hiroshima J. Med. Sci., 49, No. 1, 43-48 (2000).
13. W. C. Van Voorhis, L. K. Barrett, Y. T. Sweeney, et al., Infect. Immun., 65, No. 6, 2175-2182 (1997).
14. Y. Zhang, M. Broser, H. Cohen, et al., J. Clin. Invest., 95, No. 2, 586-592 (1995).
15. Y. Zhao, N. Chegini, and K. C. Flanders, J. Clin. Endocrinol. Metab., 79, No. 4, 1177-1184 (1994).